Is the surgical community prepared to face patients with SARS-CoV-2-induced cell death and organ injury in the post-pandemic era?  

作　　者：Sanketh Rampes Sufia Ruhomaun Qiang Shu Daqing Ma 

机构地区：[1]Division of Anaesthetics,Pain Medicine and Intensive Care,Department of Surgery and Cancer,Faculty of Medicine,Imperial College London,Chelsea and Westminster Hospital,London,UK [2]Department of Thoracic and Cardiovascular Surgery,The Children’s Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou,China Hangzhou,China

出　　处：《Burns & Trauma》2023年第1期825-827,共3页烧伤与创伤（英文）

基　　金：funded by grants from the British Journal of Anaesthesia,London,UK and the European Society of Anesthesiology and Intensive Care,Brussels,Belgium.

摘　　要：Coronavirus disease 2019(COVID-19)has caused>760 million SARS-CoV-2 infections and 6.9 million deaths globally as reported by the World Health Organization(WHO).The virus is predominately a respiratory virus,but it has wellestablished effects on many organs,producing both shortterm and long-term sequelae[1].Studies early in the pandemic showed that perioperative COVID-19 was associated with significant increases in postoperative complications and mortality.This led to governing medical organizations in the UK recommending that elective surgery should be delayed 7 weeks after COVID-19 infection,and possibly longer for those with ongoing symptoms at 7 weeks[1,2].COVID-19 presents novel challenges to patients and the surgical community worldwide,highlighting the need for renewed focus on perioperative care.

关 键 词：PATIENTS ORGANS MORTALITY 

分 类 号：R373[医药卫生—病原生物学]